Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

JP Morgan Maintains Underweight on CME Group, Raises Price Target to $252

Author: Benzinga Newsdesk | September 25, 2025 08:39am
JP Morgan analyst Kenneth Worthington maintains CME Group (NASDAQ: CME) with a Underweight and raises the price target from $246 to $252.

Posted In: CME

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist